NEW YORK, March 14, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Global Eagle Entertainment Inc. securities (NASDAQ:ENT) from November 9, 2016 through February 20, 2017, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Global Eagle investors under the federal securities laws.
To join the Global Eagle class action, go to http://www.rosenlegal.com/cases-1058.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Global Eagle’s remediation plans to address the material weaknesses in its internal controls over financial reporting were deficient; and (2) as a result, Defendants’ statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times. On February 21, 2017, Global Eagle announced that Chief Executive Officer Dave Davis and Chief Financial Officer Tom Severson both resigned effective February 20, 2017. Global Eagle also disclosed that it “expects to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2016 after the March 16, 2017 U.S. Securities and Exchange Commission deadline.” On this news, shares of Global Eagle fell $1.98 per share or over 31.8% over two trading days to close at $4.24 per share on February 22, 2017, damaging investors.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 24, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1058.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
U.S. Airline Flight Cancellations Surge After Venezuela Military Operation and FAA Airspace Closures
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Tesla Poised for Breakout Year in 2026 as New Products and EV Market Reset Drive Growth
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement 



